社区
首页
集团介绍
社区
资讯
行情
学堂
TigerAI
登录
注册
Silexion Therapeutics Corp(SLXN)
盘后
3.95
-0.12
-2.95%
19:59 EDT
4.07
-0.86
-17.44%
行情数据延迟15分钟
社区
社区
资讯
资讯
资料
资料
公告
公告
最新
推荐
zeroxu666
·
07-09
$Silexion Therapeutics Corp(SLXN)$
研究显示，SIL204 对携带 KRAS G12D 突变的肺癌细胞表现出显著的剂量依赖性抑制，且疗效显著，凸显了 SIL204 作为肺癌多功能治疗药物的潜力。研究结果还支持 Silexion 的脂质结合递送系统能够增强 SIL204 药物进入肿瘤细胞的能力，从而克服了 siRNA 技术已知的障碍，而这一障碍对于实体瘤的治疗效果至关重要。
$Silexion Therapeutics Corp(SLXN)$ 研究显示，SIL204 对携带 KRAS G12D 突变的肺癌细胞表现出显著的剂量依...
回复
评论
点赞
2
编组 21备份 2
分享
举报
zeroxu666
·
04-23
$Silexion Therapeutics Corp(SLXN)$
有消息，但是非重大利好
$Silexion Therapeutics Corp(SLXN)$ 有消息，但是非重大利好
回复
评论
点赞
1
编组 21备份 2
分享
举报
zeroxu666
·
02-27
$Silexion Therapeutics Corp(SLXN)$
有大单买入，大涨后没大跌，最近持续关注
$Silexion Therapeutics Corp(SLXN)$ 有大单买入，大涨后没大跌，最近持续关注
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
zeroxu666
·
02-25
$Silexion Therapeutics Corp(SLXN)$
研究结果很积极
$Silexion Therapeutics Corp(SLXN)$ 研究结果很积极
精彩
zeroxu666:
@常清静 这个准备起来，可以看看
回复
1
点赞
点赞
编组 21备份 2
分享
举报
zeroxu666
·
02-26
$Silexion Therapeutics Corp(SLXN)$
有大单买入没出来
$Silexion Therapeutics Corp(SLXN)$ 有大单买入没出来
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
zeroxu666
·
02-26
$Silexion Therapeutics Corp(SLXN)$
有大单买入，不知道是庄家，还是有人被套
$Silexion Therapeutics Corp(SLXN)$ 有大单买入，不知道是庄家，还是有人被套
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
zeroxu666
·
02-25
$Silexion Therapeutics Corp(SLXN)$
盘前买的早，吃到一点也是肉
$Silexion Therapeutics Corp(SLXN)$ 盘前买的早，吃到一点也是肉
# 晒晒更赚钱
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
zeroxu666
·
01-28
$Silexion Therapeutics Corp(SLXN)$
这个公司有点意思，买点放着
$Silexion Therapeutics Corp(SLXN)$ 这个公司有点意思，买点放着
精彩
坤坤的交易员:
1.86还买吗，不会太高吗
回复
3
点赞
点赞
编组 21备份 2
分享
举报
加载更多
公司概况
公司名称
Silexion Therapeutics Corp
所属市场
NASDAQ
成立日期
- -
员工人数
- -
办公地址
- -
公司网址
http://www.silexion.com
邮政编码
- -
联系电话
- -
联系传真
- -
公司概况
Silexion Therapeutics Corp是一家开曼群岛豁免公司。Silexion Therapeutics Ltd.是Biomotion Sciences的子公司。Silexion Therapeutics Ltd.是一家临床阶段、专注于肿瘤学的生物技术公司，致力于发现和开发KRAS驱动的癌症的专有疗法。Silexion的主要候选产品SIL-204B由局部给药的小干扰RNA或siRNA组成，采用缓释制剂，作为局部晚期胰腺癌患者的一线治疗，与标准护理化疗相结合。SIL-204B是继Silexion的第一代siRNA候选产品SIG12D-LODER（也称为Loder）的1期和2期临床试验之后的第二代siRNA候选产品。尽管未确定最大耐受剂量，但1期临床试验同时达到了主要和次要终点。在2期临床试验中，虽然没有达到所有患者的主要终点，但结果显示KRAS G12D/V突变患者的治疗组之间存在差异趋势，Loder组的总体生存期优势为9.3个月。关于2期临床试验中的次要安全性终点，达到了终点。对于次要疗效终点，未观察到统计学上的显著差异，也没有足够的数据进行评估。由于1期和2期试验的规模较小，它们没有提供统计学意义。
09-12 12:00
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
09-11 12:00
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
09-05
招股说明书
Form S-1 - General form for registration of securities under the Securities Act of 1933
Form S-1 - General form for registration of securities under the Securities Act of 1933
09-04
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
09-02
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
08-26
招股说明书
Form S-1 - General form for registration of securities under the Securities Act of 1933
Form S-1 - General form for registration of securities under the Securities Act of 1933
08-20
员工持股计划
Form S-8 - Securities to be offered to employees in employee benefit plans
Form S-8 - Securities to be offered to employees in employee benefit plans
08-20
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
08-19
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
08-12
季度报告
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08-12
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
08-01
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
07-31
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
07-29
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
07-21
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
分时
5日
日
周
月
数据加载中...
最高
4.69
今开
4.63
量比
0.32
最低
3.94
昨收
4.93
换手率
333.55%
热议股票
{"pagemeta":{"title":"Silexion Therapeutics Corp(SLXN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Silexion Therapeutics Corp(SLXN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Silexion Therapeutics Corp,SLXN,Silexion Therapeutics Corp股票,Silexion Therapeutics Corp股票老虎,Silexion Therapeutics Corp股票老虎国际,Silexion Therapeutics Corp行情,Silexion Therapeutics Corp股票行情,Silexion Therapeutics Corp股价,Silexion Therapeutics Corp股市,Silexion Therapeutics Corp股票价格,Silexion Therapeutics Corp股票交易,Silexion Therapeutics Corp股票购买,Silexion Therapeutics Corp股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Silexion Therapeutics Corp(SLXN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Silexion Therapeutics Corp(SLXN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}},"tab":"community","symbol":"SLXN","data":{"stockData":{"symbol":"SLXN","market":"US","secType":"STK","nameCN":"Silexion Therapeutics Corp","latestPrice":4.07,"timestamp":1757707200000,"preClose":4.93,"halted":0,"volume":1163424,"hourTrading":{"tag":"盘后","latestPrice":3.95,"preClose":4.07,"latestTime":"19:59 EDT","volume":84515,"amount":335090.1601,"timestamp":1757721592904},"delay":0,"floatShares":348800,"shares":731642,"eps":-395.362,"marketStatus":"休市中","change":-0.86,"latestTime":"09-12 16:00:00 EDT","open":4.63,"high":4.6944,"low":3.9411,"amount":5102304.615801601,"amplitude":0.152799,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-395.362,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1757923200000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":4.93,"preHourTrading":{"tag":"盘前","latestPrice":4.74,"preClose":4.93,"latestTime":"09:27 EDT","volume":52113,"amount":245532.119229,"timestamp":1757683653132},"postHourTrading":{"tag":"盘后","latestPrice":3.95,"preClose":4.07,"latestTime":"19:59 EDT","volume":84515,"amount":335090.1601,"timestamp":1757721592904},"volumeRatio":0.31922648560659594},"tweetData":{"bottom":false,"list":[{"cardType":"TWEET","cardId":"TWEET.454849880555720","cardData":[{"tweetId":"454849880555720","author":{"authorId":"3544572238091832","idStr":"3544572238091832","name":"zeroxu666","avatar":"https://static.laohu8.com/default-avatar.jpg","userType":1,"introduction":"","userGiftHeadFrame":"https://static.tigerbbs.com/0a8758340a08196056f8bc1e54805193","crmLevel":5,"crmLevelSwitch":0,"wearingBadge":{"badgeId":"35ec162348d5460f88c959321e554969-3","templateUuid":"35ec162348d5460f88c959321e554969","name":"Legendary Trader","description":"Total number of securities or futures transactions reached 300","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"93.57%","individualDisplayEnabled":0,"individualDisplaySort":0},"individualDisplayBadges":[],"fanSize":55,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"digest":"<a href=\"https://laohu8.com/S/SLXN\">$Silexion Therapeutics Corp(SLXN)$</a> 研究显示，SIL204 对携带 KRAS G12D 突变的肺癌细胞表现出显著的剂量依赖性抑制，且疗效显著，凸显了 SIL204 作为肺癌多功能治疗药物的潜力。研究结果还支持 Silexion 的脂质结合递送系统能够增强 SIL204 药物进入肿瘤细胞的能力，从而克服了 siRNA 技术已知的障碍，而这一障碍对于实体瘤的治疗效果至关重要。","plainDigest":"$Silexion Therapeutics Corp(SLXN)$ 研究显示，SIL204 对携带 KRAS G12D 突变的肺癌细胞表现出显著的剂量依赖性抑制，且疗效显著，凸显了 SIL204 作为肺癌多功能治疗药物的潜力。研究结果还支持 Silexion 的脂质结合递送系统能够增强 SIL204 药物进入肿瘤细胞的能力，从而克服了 siRNA 技术已知的障碍，而这一障碍对于实体瘤的治疗效果至关重要。","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1752065200282,"gmtModify":1752065202122,"symbols":["SLXN"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":571,"likeCount":2,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/454849880555720","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":300,"displayRows":2,"foldSize":0,"authorId":"3544572238091832"}],"position":0},{"cardType":"TWEET","cardId":"TWEET.427596004454936","cardData":[{"tweetId":"427596004454936","author":{"authorId":"3544572238091832","idStr":"3544572238091832","name":"zeroxu666","avatar":"https://static.laohu8.com/default-avatar.jpg","userType":1,"introduction":"","userGiftHeadFrame":"https://static.tigerbbs.com/0a8758340a08196056f8bc1e54805193","crmLevel":5,"crmLevelSwitch":0,"wearingBadge":{"badgeId":"35ec162348d5460f88c959321e554969-3","templateUuid":"35ec162348d5460f88c959321e554969","name":"Legendary Trader","description":"Total number of securities or futures transactions reached 300","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"93.57%","individualDisplayEnabled":0,"individualDisplaySort":0},"individualDisplayBadges":[],"fanSize":55,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"digest":"<a href=\"https://laohu8.com/S/SLXN\">$Silexion Therapeutics Corp(SLXN)$</a> 有消息，但是非重大利好","plainDigest":"$Silexion Therapeutics Corp(SLXN)$ 有消息，但是非重大利好","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1745416751523,"gmtModify":1745416752893,"symbols":["SLXN"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":390,"likeCount":1,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/427596004454936","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":53,"displayRows":2,"foldSize":0,"authorId":"3544572238091832"}],"position":0},{"cardType":"TWEET","cardId":"TWEET.407986880909640","cardData":[{"tweetId":"407986880909640","author":{"authorId":"3544572238091832","idStr":"3544572238091832","name":"zeroxu666","avatar":"https://static.laohu8.com/default-avatar.jpg","userType":1,"introduction":"","userGiftHeadFrame":"https://static.tigerbbs.com/0a8758340a08196056f8bc1e54805193","crmLevel":5,"crmLevelSwitch":0,"wearingBadge":{"badgeId":"35ec162348d5460f88c959321e554969-3","templateUuid":"35ec162348d5460f88c959321e554969","name":"Legendary Trader","description":"Total number of securities or futures transactions reached 300","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"93.57%","individualDisplayEnabled":0,"individualDisplaySort":0},"individualDisplayBadges":[],"fanSize":55,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"digest":"<a href=\"https://laohu8.com/S/SLXN\">$Silexion Therapeutics Corp(SLXN)$</a> 有大单买入，大涨后没大跌，最近持续关注","plainDigest":"$Silexion Therapeutics Corp(SLXN)$ 有大单买入，大涨后没大跌，最近持续关注","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1740621043412,"gmtModify":1740621044897,"symbols":["SLXN"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":290,"likeCount":0,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/407986880909640","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":68,"displayRows":2,"foldSize":0,"authorId":"3544572238091832"}],"position":0},{"cardType":"TWEET","cardId":"TWEET.407439646355896","cardData":[{"tweetId":"407439646355896","author":{"authorId":"3544572238091832","idStr":"3544572238091832","name":"zeroxu666","avatar":"https://static.laohu8.com/default-avatar.jpg","userType":1,"introduction":"","userGiftHeadFrame":"https://static.tigerbbs.com/0a8758340a08196056f8bc1e54805193","crmLevel":5,"crmLevelSwitch":0,"wearingBadge":{"badgeId":"35ec162348d5460f88c959321e554969-3","templateUuid":"35ec162348d5460f88c959321e554969","name":"Legendary Trader","description":"Total number of securities or futures transactions reached 300","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"93.57%","individualDisplayEnabled":0,"individualDisplaySort":0},"individualDisplayBadges":[],"fanSize":55,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"digest":"<a href=\"https://laohu8.com/S/SLXN\">$Silexion Therapeutics Corp(SLXN)$</a> 研究结果很积极","plainDigest":"$Silexion Therapeutics Corp(SLXN)$ 研究结果很积极","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1740491503704,"gmtModify":1740491504977,"symbols":["SLXN"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":630,"likeCount":0,"liked":false,"collected":false,"commentCount":1,"hotComments":[{"id":"407442558833144","author":{"authorId":"3544572238091832","idStr":"3544572238091832","name":"zeroxu666","avatar":"https://static.laohu8.com/default-avatar.jpg","userType":1,"introduction":"","userGiftHeadFrame":"https://static.tigerbbs.com/0a8758340a08196056f8bc1e54805193","crmLevel":5,"crmLevelSwitch":0,"fanSize":55,"starInvestorFlag":false},"content":"@常清静 这个准备起来，可以看看","plainContent":"@常清静 这个准备起来，可以看看","likeCount":0,"commentType":"valid","coins":0}],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/407439646355896","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":46,"displayRows":2,"foldSize":0,"authorId":"3544572238091832"}],"position":0},{"cardType":"TWEET","cardId":"TWEET.407801160778080","cardData":[{"tweetId":"407801160778080","author":{"authorId":"3544572238091832","idStr":"3544572238091832","name":"zeroxu666","avatar":"https://static.laohu8.com/default-avatar.jpg","userType":1,"introduction":"","userGiftHeadFrame":"https://static.tigerbbs.com/0a8758340a08196056f8bc1e54805193","crmLevel":5,"crmLevelSwitch":0,"wearingBadge":{"badgeId":"35ec162348d5460f88c959321e554969-3","templateUuid":"35ec162348d5460f88c959321e554969","name":"Legendary Trader","description":"Total number of securities or futures transactions reached 300","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"93.57%","individualDisplayEnabled":0,"individualDisplaySort":0},"individualDisplayBadges":[],"fanSize":55,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"digest":"<a href=\"https://laohu8.com/S/SLXN\">$Silexion Therapeutics Corp(SLXN)$</a> 有大单买入没出来","plainDigest":"$Silexion Therapeutics Corp(SLXN)$ 有大单买入没出来","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1740575976113,"gmtModify":1740575977372,"symbols":["SLXN"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":547,"likeCount":0,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/407801160778080","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":48,"displayRows":2,"foldSize":0,"authorId":"3544572238091832"}],"position":0},{"cardType":"TWEET","cardId":"TWEET.407473839936040","cardData":[{"tweetId":"407473839936040","author":{"authorId":"3544572238091832","idStr":"3544572238091832","name":"zeroxu666","avatar":"https://static.laohu8.com/default-avatar.jpg","userType":1,"introduction":"","userGiftHeadFrame":"https://static.tigerbbs.com/0a8758340a08196056f8bc1e54805193","crmLevel":5,"crmLevelSwitch":0,"wearingBadge":{"badgeId":"35ec162348d5460f88c959321e554969-3","templateUuid":"35ec162348d5460f88c959321e554969","name":"Legendary Trader","description":"Total number of securities or futures transactions reached 300","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"93.57%","individualDisplayEnabled":0,"individualDisplaySort":0},"individualDisplayBadges":[],"fanSize":55,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"digest":"<a href=\"https://laohu8.com/S/SLXN\">$Silexion Therapeutics Corp(SLXN)$</a> 有大单买入，不知道是庄家，还是有人被套","plainDigest":"$Silexion Therapeutics Corp(SLXN)$ 有大单买入，不知道是庄家，还是有人被套","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1740499333637,"gmtModify":1740499335097,"symbols":["SLXN"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":200,"likeCount":0,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/407473839936040","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":68,"displayRows":2,"foldSize":0,"authorId":"3544572238091832"}],"position":0},{"cardType":"TWEET","cardId":"TWEET.407472340603528","cardData":[{"tweetId":"407472340603528","author":{"authorId":"3544572238091832","idStr":"3544572238091832","name":"zeroxu666","avatar":"https://static.laohu8.com/default-avatar.jpg","userType":1,"introduction":"","userGiftHeadFrame":"https://static.tigerbbs.com/0a8758340a08196056f8bc1e54805193","crmLevel":5,"crmLevelSwitch":0,"wearingBadge":{"badgeId":"35ec162348d5460f88c959321e554969-3","templateUuid":"35ec162348d5460f88c959321e554969","name":"Legendary Trader","description":"Total number of securities or futures transactions reached 300","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"93.57%","individualDisplayEnabled":0,"individualDisplaySort":0},"individualDisplayBadges":[],"fanSize":55,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"digest":"<a href=\"https://laohu8.com/S/SLXN\">$Silexion Therapeutics Corp(SLXN)$</a> 盘前买的早，吃到一点也是肉","plainDigest":"$Silexion Therapeutics Corp(SLXN)$ 盘前买的早，吃到一点也是肉","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1740498846204,"gmtModify":1740499215666,"symbols":["SLXN"],"themeIds":["5bfad02ab61749c8bfe6573ac7bbe8a3"],"themes":[{"themeId":"5bfad02ab61749c8bfe6573ac7bbe8a3","themeType":0,"name":"晒晒更赚钱"}],"popularizeThemeFlag":false,"imageCount":1,"images":[{"url":"https://static.tigerbbs.com/7af5153c1a548a19adc955870cf2f4a3","width":"972","height":"1631"}],"repostCount":0,"viewCount":590,"likeCount":0,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/407472340603528","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":["晒单贴"],"commentAndTweetFlag":false,"upFlag":false,"length":57,"displayRows":2,"foldSize":0,"authorId":"3544572238091832"}],"position":0},{"cardType":"TWEET","cardId":"TWEET.397473910452704","cardData":[{"tweetId":"397473910452704","author":{"authorId":"3544572238091832","idStr":"3544572238091832","name":"zeroxu666","avatar":"https://static.laohu8.com/default-avatar.jpg","userType":1,"introduction":"","userGiftHeadFrame":"https://static.tigerbbs.com/0a8758340a08196056f8bc1e54805193","crmLevel":5,"crmLevelSwitch":0,"wearingBadge":{"badgeId":"35ec162348d5460f88c959321e554969-3","templateUuid":"35ec162348d5460f88c959321e554969","name":"Legendary Trader","description":"Total number of securities or futures transactions reached 300","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"93.57%","individualDisplayEnabled":0,"individualDisplaySort":0},"individualDisplayBadges":[],"fanSize":55,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"digest":"<a href=\"https://laohu8.com/S/SLXN\">$Silexion Therapeutics Corp(SLXN)$</a> 这个公司有点意思，买点放着","plainDigest":"$Silexion Therapeutics Corp(SLXN)$ 这个公司有点意思，买点放着","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1738079621028,"gmtModify":1738079622538,"symbols":["SLXN"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":1603,"likeCount":0,"liked":false,"collected":false,"commentCount":3,"hotComments":[{"id":"397748776391152","author":{"authorId":"4197626987889112","idStr":"4197626987889112","name":"坤坤的交易员","avatar":"https://static.tigerbbs.com/46460d3b5a12b52f81291f5d9f8fb26f","userType":1,"introduction":"","crmLevel":1,"crmLevelSwitch":0,"fanSize":3,"starInvestorFlag":false},"content":"1.86还买吗，不会太高吗","plainContent":"1.86还买吗，不会太高吗","likeCount":0,"commentType":"valid","coins":0}],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/397473910452704","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":57,"displayRows":2,"foldSize":0,"authorId":"3544572238091832"}],"position":0}],"size":8,"extra":{"requestId":"66ba0c9d35a8427e9d97f68ef4f9171e","feedVerCode":"2"}},"newsData":null,"noticeData":{"listData":[{"cdn_pdf":false,"hasAttachments":true,"id":"20165817","market":"us","labels":[],"media":"sec.gov","original_id":"AN117891325003309-SLXN","pdf_url":"","pub_time":1757649600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"SLXN","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003309/0001178913-25-003309-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"EXHIBIT 4.1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003309/exhibit_4-1.htm","primary":true,"translateUrl":"","linkName":"exhibit_4-1.htm","type":"EX-4.1","id":"NTFILE9yVNTFAyeS75f1tW","market":"us","size":99922},{"description":"8-K","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003309/zk2533780.htm","primary":false,"translateUrl":"","linkName":"zk2533780.htm","type":"8-K","id":"NTFILEkyBwrfDQ2GcS5BxB","market":"us","size":66789},{"description":"EXHIBIT 4.2","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003309/exhibit_4-2.htm","primary":false,"translateUrl":"","linkName":"exhibit_4-2.htm","type":"EX-4.2","id":"NTFILECuRttnu4Y3VqM3PX","market":"us","size":101136},{"description":"EXHIBIT 4.3","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003309/exhibit_4-3.htm","primary":false,"translateUrl":"","linkName":"exhibit_4-3.htm","type":"EX-4.3","id":"NTFILE5uwCnmiborHQxBK1","market":"us","size":98141},{"description":"EXHIBIT 4.4","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003309/exhibit_4-4.htm","primary":false,"translateUrl":"","linkName":"exhibit_4-4.htm","type":"EX-4.4","id":"NTFILEFM6PeCAnVrZXa2L1","market":"us","size":101745},{"description":"EXHIBIT 10.1","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003309/exhibit_10-1.htm","primary":false,"translateUrl":"","linkName":"exhibit_10-1.htm","type":"EX-10.1","id":"NTFILECzG6yVCMV81CSZ8F","market":"us","size":204902},{"description":"EXHIBIT 99.1","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003309/exhibit_99-1.htm","primary":false,"translateUrl":"","linkName":"exhibit_99-1.htm","type":"EX-99.1","id":"NTFILEHgUk5c2z6uVvZQEf","market":"us","size":11911},{"description":"","seq":12,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003309/image00001.jpg","primary":false,"translateUrl":"","linkName":"image00001.jpg","type":"GRAPHIC","id":"NTFILE9KEa71k1RhtmWAhJ","market":"us","size":27528}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2025-09-12 12:00","pubTimestamp":1757649600,"title_zh":"Form 8-K - Current report","summary_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第1.01项：签订重大最终协议；项目9.01：财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20156696","market":"us","labels":[],"media":"sec.gov","original_id":"AN117891325003292-SLXN","pdf_url":"","pub_time":1757563200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"SLXN","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003292/0001178913-25-003292-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 7.01: Regulation FD Disclosure;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"EXHIBIT 99.1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003292/exhibit_99-1.htm","primary":true,"translateUrl":"","linkName":"exhibit_99-1.htm","type":"EX-99.1","id":"NTFILE8NDHB2ThCsT2RMwY","market":"us","size":19321},{"description":"8-K","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003292/zk2533776.htm","primary":false,"translateUrl":"","linkName":"zk2533776.htm","type":"8-K","id":"NTFILEF4dmBym9nhaPUAh9","market":"us","size":49028},{"description":"","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003292/image00001.jpg","primary":false,"translateUrl":"","linkName":"image00001.jpg","type":"GRAPHIC","id":"NTFILE9ALfMnweNNvWugtM","market":"us","size":27528},{"description":"","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003292/image2.jpg","primary":false,"translateUrl":"","linkName":"image2.jpg","type":"GRAPHIC","id":"NTFILEGFRYoykCdHEBPks4","market":"us","size":631},{"description":"","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003292/image00003.jpg","primary":false,"translateUrl":"","linkName":"image00003.jpg","type":"GRAPHIC","id":"NTFILE6rnsz1JcTiYFrpsi","market":"us","size":37645}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2025-09-11 12:00","pubTimestamp":1757563200,"title_zh":"Form 8-K - Current report","summary_en":"Item 7.01: Regulation FD Disclosure;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第7.01项：法规FD披露；项目9.01：财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20135669","market":"us","labels":[],"media":"sec.gov","original_id":"AN117891325003260-SLXN","pdf_url":"","pub_time":1757044800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form S-1 - General form for registration of securities under the Securities Act of 1933","symbol":"SLXN","title":"Form S-1 - General form for registration of securities under the Securities Act of 1933","titleType":"招股说明书","type":"usProspectusesRegistrations","url":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003260/0001178913-25-003260-index.htm","us_notice_code":"Form S-1","us_title_en":"Form S-1 - General form for registration of securities under the Securities Act of 1933","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"S-1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003260/zk2533684.htm","primary":true,"translateUrl":"","linkName":"zk2533684.htm","type":"S-1","id":"NTFILE2YPVf5ryDDjyagto","market":"us","size":4176639},{"description":"EXHIBIT 4.11","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003260/exhibit_4-11.htm","primary":false,"translateUrl":"","linkName":"exhibit_4-11.htm","type":"EX-4.11","id":"NTFILEA6TE3PrnKvaYRT3s","market":"us","size":99925},{"description":"EXHIBIT 4.12","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003260/exhibit_4-12.htm","primary":false,"translateUrl":"","linkName":"exhibit_4-12.htm","type":"EX-4.12","id":"NTFILEGUZ3gTEgiewVypXX","market":"us","size":101183},{"description":"EXHIBIT 4.13","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003260/exhibit_4-13.htm","primary":false,"translateUrl":"","linkName":"exhibit_4-13.htm","type":"EX-4.13","id":"NTFILEADtKYYksNyArzf5m","market":"us","size":95084},{"description":"PLACEMENT AGENT ORDINARY SHARE PURCHASE WARRANT","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003260/exhibit_4-14.htm","primary":false,"translateUrl":"","linkName":"exhibit_4-14.htm","type":"EX-4.14","id":"NTFILECe456mnc2w5frPjy","market":"us","size":100498},{"description":"EXHIBIT 5.1","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003260/exhibit_5-1.htm","primary":false,"translateUrl":"","linkName":"exhibit_5-1.htm","type":"EX-5.1","id":"NTFILEECaiQcq2Wsy5f25W","market":"us","size":45838},{"description":"EXHIBIT 5.2","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003260/exhibit_5-2.htm","primary":false,"translateUrl":"","linkName":"exhibit_5-2.htm","type":"EX-5.2","id":"NTFILE2JcxA6agL89pqqVD","market":"us","size":13390},{"description":"EXHIBIT 10.2","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003260/exhibit_10-12.htm","primary":false,"translateUrl":"","linkName":"exhibit_10-12.htm","type":"EX-10.12","id":"NTFILE4LLHrE3h3C6tPjSX","market":"us","size":207906},{"description":"EXHIBIT 10.13","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003260/exhibit_10-13.htm","primary":false,"translateUrl":"","linkName":"exhibit_10-13.htm","type":"EX-10.13","id":"NTFILECSND6FzsBbSBgPAq","market":"us","size":55075},{"description":"EXHIBIT 23.1","seq":10,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003260/exhibit_23-1.htm","primary":false,"translateUrl":"","linkName":"exhibit_23-1.htm","type":"EX-23.1","id":"NTFILE8odGa85mWijmj8Zu","market":"us","size":3388},{"description":"FILING FEE IXBRL","seq":11,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003260/ex107.htm","primary":false,"translateUrl":"","linkName":"ex107.htm","type":"EX-FILING FEES","id":"NTFILECpf7YABcQiDfnpub","market":"us","size":35839},{"description":"GRAPHIC","seq":17,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003260/image00007.jpg","primary":false,"translateUrl":"","linkName":"image00007.jpg","type":"GRAPHIC","id":"NTFILE7U7XYxAXbMZYYeCb","market":"us","size":3975},{"description":"GRAPHIC","seq":18,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003260/image006.jpg","primary":false,"translateUrl":"","linkName":"image006.jpg","type":"GRAPHIC","id":"NTFILECrSqb7pX95HsHC9k","market":"us","size":29954},{"description":"GRAPHIC","seq":19,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003260/image1.jpg","primary":false,"translateUrl":"","linkName":"image1.jpg","type":"GRAPHIC","id":"NTFILEBWxerf317j7mXcMK","market":"us","size":444330},{"description":"GRAPHIC","seq":20,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003260/image00002.jpg","primary":false,"translateUrl":"","linkName":"image00002.jpg","type":"GRAPHIC","id":"NTFILEFzyGjWEaKyYkEkVf","market":"us","size":16772},{"description":"GRAPHIC","seq":21,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003260/image00003.jpg","primary":false,"translateUrl":"","linkName":"image00003.jpg","type":"GRAPHIC","id":"NTFILEFPZyRGgkBK6FXJqT","market":"us","size":44106},{"description":"GRAPHIC","seq":22,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003260/image00004.jpg","primary":false,"translateUrl":"","linkName":"image00004.jpg","type":"GRAPHIC","id":"NTFILE8b8b55uFhHn9itLs","market":"us","size":24516},{"description":"GRAPHIC","seq":23,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003260/image00005.jpg","primary":false,"translateUrl":"","linkName":"image00005.jpg","type":"GRAPHIC","id":"NTFILEFynEu4hNPJbsoFhV","market":"us","size":28406},{"description":"GRAPHIC","seq":24,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003260/image00023.jpg","primary":false,"translateUrl":"","linkName":"image00023.jpg","type":"GRAPHIC","id":"NTFILE3dQGkiw9ErZqejai","market":"us","size":24654},{"description":"GRAPHIC","seq":25,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003260/image00024.jpg","primary":false,"translateUrl":"","linkName":"image00024.jpg","type":"GRAPHIC","id":"NTFILEDW43KbpsFYYcueMf","market":"us","size":4463},{"description":"GRAPHIC","seq":26,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003260/image8.jpg","primary":false,"translateUrl":"","linkName":"image8.jpg","type":"GRAPHIC","id":"NTFILEF6UW3HNiNy2D4dNZ","market":"us","size":719455},{"description":"GRAPHIC","seq":27,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003260/image00012.jpg","primary":false,"translateUrl":"","linkName":"image00012.jpg","type":"GRAPHIC","id":"NTFILEE25vGn3QwrfymSbr","market":"us","size":41035},{"description":"GRAPHIC","seq":28,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003260/image00013.jpg","primary":false,"translateUrl":"","linkName":"image00013.jpg","type":"GRAPHIC","id":"NTFILE5gk91KRLBLmFrv4o","market":"us","size":32327},{"description":"GRAPHIC","seq":29,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003260/image00010.jpg","primary":false,"translateUrl":"","linkName":"image00010.jpg","type":"GRAPHIC","id":"NTFILECQWefQTsynTB3L7S","market":"us","size":25509},{"description":"GRAPHIC","seq":30,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003260/image00014.jpg","primary":false,"translateUrl":"","linkName":"image00014.jpg","type":"GRAPHIC","id":"NTFILE2MWuTaKuzfcqWhj6","market":"us","size":24964},{"description":"GRAPHIC","seq":31,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003260/image00015.jpg","primary":false,"translateUrl":"","linkName":"image00015.jpg","type":"GRAPHIC","id":"NTFILECjeXrX5C6voNt3J3","market":"us","size":29954},{"description":"GRAPHIC","seq":32,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003260/image00016.jpg","primary":false,"translateUrl":"","linkName":"image00016.jpg","type":"GRAPHIC","id":"NTFILEAFFyxbxRczmjdFwd","market":"us","size":27884},{"description":"GRAPHIC","seq":33,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003260/image00017.jpg","primary":false,"translateUrl":"","linkName":"image00017.jpg","type":"GRAPHIC","id":"NTFILE2jKZS9VAGX9wkmug","market":"us","size":49365},{"description":"GRAPHIC","seq":34,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003260/image00018.jpg","primary":false,"translateUrl":"","linkName":"image00018.jpg","type":"GRAPHIC","id":"NTFILEAxWDKF6cGDLmyExs","market":"us","size":35041},{"description":"GRAPHIC","seq":35,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003260/image00019.jpg","primary":false,"translateUrl":"","linkName":"image00019.jpg","type":"GRAPHIC","id":"NTFILEEMQ6tEPpS5aNRnuJ","market":"us","size":29751},{"description":"GRAPHIC","seq":36,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003260/image00020.jpg","primary":false,"translateUrl":"","linkName":"image00020.jpg","type":"GRAPHIC","id":"NTFILE8XX733ENDQWd41p8","market":"us","size":26800},{"description":"GRAPHIC","seq":37,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003260/image00021.jpg","primary":false,"translateUrl":"","linkName":"image00021.jpg","type":"GRAPHIC","id":"NTFILE97joeR356vFdk6qR","market":"us","size":30285},{"description":"GRAPHIC","seq":38,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003260/image00022.jpg","primary":false,"translateUrl":"","linkName":"image00022.jpg","type":"GRAPHIC","id":"NTFILE6Mrz9mDyUpX3paff","market":"us","size":25054}],"type_name":"招股注册","type_name_en":"Recruitment Registration","titleTypeEn":"Public Prospectus","us_type":"usProspectusesRegistrations","us_type_zh":"招股注册","earn_infos":[],"event_type":"important_notice","event_name":"招股说明书","pubTime":"2025-09-05 12:00","pubTimestamp":1757044800,"title_zh":"Form S-1 - General form for registration of securities under the Securities Act of 1933","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20130853","market":"us","labels":[],"media":"sec.gov","original_id":"AN117891325003248-SLXN","pdf_url":"","pub_time":1756958400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"SLXN","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003248/0001178913-25-003248-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 7.01: Regulation FD Disclosure;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"EXHIBIT 99.1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003248/exhibit_99-1.htm","primary":true,"translateUrl":"","linkName":"exhibit_99-1.htm","type":"EX-99.1","id":"NTFILE7hSwUViVVUvzMYJW","market":"us","size":14386},{"description":"8-K","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003248/zk2533756.htm","primary":false,"translateUrl":"","linkName":"zk2533756.htm","type":"8-K","id":"NTFILE6ueYGtaTHGdotvkp","market":"us","size":50213},{"description":"","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003248/image0.jpg","primary":false,"translateUrl":"","linkName":"image0.jpg","type":"GRAPHIC","id":"NTFILEBSaeYmaiH27wWDaF","market":"us","size":27951}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2025-09-04 12:00","pubTimestamp":1756958400,"title_zh":"Form 8-K - Current report","summary_en":"Item 7.01: Regulation FD Disclosure;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第7.01项：法规FD披露；项目9.01：财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20118653","market":"us","labels":[],"media":"sec.gov","original_id":"AN117891325003205-SLXN","pdf_url":"","pub_time":1756785600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"SLXN","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003205/0001178913-25-003205-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 7.01: Regulation FD Disclosure;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"EXHIBIT 99.1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003205/exhibit_99-1.htm","primary":true,"translateUrl":"","linkName":"exhibit_99-1.htm","type":"EX-99.1","id":"NTFILEBcmHQ8spxpDSyXQN","market":"us","size":63402},{"description":"8-K","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003205/zk2533739.htm","primary":false,"translateUrl":"","linkName":"zk2533739.htm","type":"8-K","id":"NTFILE9ryXGBGaycFdRKw9","market":"us","size":50304},{"description":"","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003205/exhibit_99-1slide1.jpg","primary":false,"translateUrl":"","linkName":"exhibit_99-1slide1.jpg","type":"GRAPHIC","id":"NTFILE7uP5bvzARxerdExr","market":"us","size":91547},{"description":"","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003205/exhibit_99-1slide2.jpg","primary":false,"translateUrl":"","linkName":"exhibit_99-1slide2.jpg","type":"GRAPHIC","id":"NTFILEE7vygormwP4umdFy","market":"us","size":252488},{"description":"","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003205/exhibit_99-1slide3.jpg","primary":false,"translateUrl":"","linkName":"exhibit_99-1slide3.jpg","type":"GRAPHIC","id":"NTFILE6VdVYMcaAeUET4Fk","market":"us","size":110252},{"description":"","seq":10,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003205/exhibit_99-1slide4.jpg","primary":false,"translateUrl":"","linkName":"exhibit_99-1slide4.jpg","type":"GRAPHIC","id":"NTFILEFFzFUZHpJNJHaBgY","market":"us","size":186267},{"description":"","seq":11,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003205/exhibit_99-1slide5.jpg","primary":false,"translateUrl":"","linkName":"exhibit_99-1slide5.jpg","type":"GRAPHIC","id":"NTFILEG85As3EB1avyTUru","market":"us","size":99149},{"description":"","seq":12,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003205/exhibit_99-1slide6.jpg","primary":false,"translateUrl":"","linkName":"exhibit_99-1slide6.jpg","type":"GRAPHIC","id":"NTFILE7cUoYUf1Cy2jFLXC","market":"us","size":65677},{"description":"","seq":13,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003205/exhibit_99-1slide7.jpg","primary":false,"translateUrl":"","linkName":"exhibit_99-1slide7.jpg","type":"GRAPHIC","id":"NTFILECwu7oyGN7j1g3tKt","market":"us","size":121818},{"description":"","seq":14,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003205/exhibit_99-1slide8.jpg","primary":false,"translateUrl":"","linkName":"exhibit_99-1slide8.jpg","type":"GRAPHIC","id":"NTFILE5jFLPCGVhaWsh3uS","market":"us","size":144362},{"description":"","seq":15,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003205/exhibit_99-1slide9.jpg","primary":false,"translateUrl":"","linkName":"exhibit_99-1slide9.jpg","type":"GRAPHIC","id":"NTFILE863CUgjAuvD6Ljko","market":"us","size":125462},{"description":"","seq":16,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003205/exhibit_99-1slide10.jpg","primary":false,"translateUrl":"","linkName":"exhibit_99-1slide10.jpg","type":"GRAPHIC","id":"NTFILE97ybL7DTkRvkfzsj","market":"us","size":68834},{"description":"","seq":17,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003205/exhibit_99-1slide11.jpg","primary":false,"translateUrl":"","linkName":"exhibit_99-1slide11.jpg","type":"GRAPHIC","id":"NTFILEAGCKAptfbVy6o7e1","market":"us","size":139099},{"description":"","seq":18,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003205/exhibit_99-1slide12.jpg","primary":false,"translateUrl":"","linkName":"exhibit_99-1slide12.jpg","type":"GRAPHIC","id":"NTFILE28yGfaVweb736eJ3","market":"us","size":140451},{"description":"","seq":19,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003205/exhibit_99-1slide13.jpg","primary":false,"translateUrl":"","linkName":"exhibit_99-1slide13.jpg","type":"GRAPHIC","id":"NTFILEGdeuX9btbYg8NdUc","market":"us","size":122901},{"description":"","seq":20,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003205/exhibit_99-1slide14.jpg","primary":false,"translateUrl":"","linkName":"exhibit_99-1slide14.jpg","type":"GRAPHIC","id":"NTFILEHJ6hBRmAczRMPZ3f","market":"us","size":158806},{"description":"","seq":21,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003205/exhibit_99-1slide15.jpg","primary":false,"translateUrl":"","linkName":"exhibit_99-1slide15.jpg","type":"GRAPHIC","id":"NTFILE8nyfjs1zrTffUkPh","market":"us","size":61758},{"description":"","seq":22,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003205/exhibit_99-1slide16.jpg","primary":false,"translateUrl":"","linkName":"exhibit_99-1slide16.jpg","type":"GRAPHIC","id":"NTFILEGVGpTB8gxQLS21za","market":"us","size":132827},{"description":"","seq":23,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003205/exhibit_99-1slide17.jpg","primary":false,"translateUrl":"","linkName":"exhibit_99-1slide17.jpg","type":"GRAPHIC","id":"NTFILEAHMvVwcgLSZ2dVaT","market":"us","size":169802},{"description":"","seq":24,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003205/exhibit_99-1slide18.jpg","primary":false,"translateUrl":"","linkName":"exhibit_99-1slide18.jpg","type":"GRAPHIC","id":"NTFILE9pqqMrYzhJucX52w","market":"us","size":105349},{"description":"","seq":25,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003205/exhibit_99-1slide19.jpg","primary":false,"translateUrl":"","linkName":"exhibit_99-1slide19.jpg","type":"GRAPHIC","id":"NTFILEG4WKFEMEf68UPjof","market":"us","size":119110},{"description":"","seq":26,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003205/exhibit_99-1slide20.jpg","primary":false,"translateUrl":"","linkName":"exhibit_99-1slide20.jpg","type":"GRAPHIC","id":"NTFILE4fJBctJY4iBQADmM","market":"us","size":117488},{"description":"","seq":27,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003205/exhibit_99-1slide21.jpg","primary":false,"translateUrl":"","linkName":"exhibit_99-1slide21.jpg","type":"GRAPHIC","id":"NTFILE4U9pHo8JEvr4U7Gj","market":"us","size":120799},{"description":"","seq":28,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003205/exhibit_99-1slide22.jpg","primary":false,"translateUrl":"","linkName":"exhibit_99-1slide22.jpg","type":"GRAPHIC","id":"NTFILEDFU7svLsgNtwHhzR","market":"us","size":145830},{"description":"","seq":29,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003205/exhibit_99-1slide23.jpg","primary":false,"translateUrl":"","linkName":"exhibit_99-1slide23.jpg","type":"GRAPHIC","id":"NTFILEBSgjCnT651kRkwgS","market":"us","size":106135},{"description":"","seq":30,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003205/exhibit_99-1slide24.jpg","primary":false,"translateUrl":"","linkName":"exhibit_99-1slide24.jpg","type":"GRAPHIC","id":"NTFILEz9gbtw9JahL52Pmw","market":"us","size":138652},{"description":"","seq":31,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003205/exhibit_99-1slide25.jpg","primary":false,"translateUrl":"","linkName":"exhibit_99-1slide25.jpg","type":"GRAPHIC","id":"NTFILE6pa3hMpZ5VSw6PaZ","market":"us","size":112914},{"description":"","seq":32,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003205/exhibit_99-1slide26.jpg","primary":false,"translateUrl":"","linkName":"exhibit_99-1slide26.jpg","type":"GRAPHIC","id":"NTFILEJCNaMqTch6qGT4pS","market":"us","size":124762},{"description":"","seq":33,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003205/exhibit_99-1slide27.jpg","primary":false,"translateUrl":"","linkName":"exhibit_99-1slide27.jpg","type":"GRAPHIC","id":"NTFILECbqpBiNTQrosRVrS","market":"us","size":144367},{"description":"","seq":34,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003205/exhibit_99-1slide28.jpg","primary":false,"translateUrl":"","linkName":"exhibit_99-1slide28.jpg","type":"GRAPHIC","id":"NTFILEAxHEQysjZjro1XU2","market":"us","size":166959},{"description":"","seq":35,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003205/exhibit_99-1slide29.jpg","primary":false,"translateUrl":"","linkName":"exhibit_99-1slide29.jpg","type":"GRAPHIC","id":"NTFILE9hY4Va2Gh8uadcb7","market":"us","size":199904},{"description":"","seq":36,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003205/exhibit_99-1slide30.jpg","primary":false,"translateUrl":"","linkName":"exhibit_99-1slide30.jpg","type":"GRAPHIC","id":"NTFILE2hkJqjbdWCk5AknL","market":"us","size":155911},{"description":"","seq":37,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003205/exhibit_99-1slide31.jpg","primary":false,"translateUrl":"","linkName":"exhibit_99-1slide31.jpg","type":"GRAPHIC","id":"NTFILEF6cTJfHF2wz5tSd8","market":"us","size":141425},{"description":"","seq":38,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003205/exhibit_99-1slide32.jpg","primary":false,"translateUrl":"","linkName":"exhibit_99-1slide32.jpg","type":"GRAPHIC","id":"NTFILEAt9E4zxEb81kgSJn","market":"us","size":95508}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2025-09-02 12:00","pubTimestamp":1756785600,"title_zh":"Form 8-K - Current report","summary_en":"Item 7.01: Regulation FD Disclosure;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第7.01项：法规FD披露；项目9.01：财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20062711","market":"us","labels":[],"media":"sec.gov","original_id":"AN117891325003107-SLXN","pdf_url":"","pub_time":1756180800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form S-1 - General form for registration of securities under the Securities Act of 1933","symbol":"SLXN","title":"Form S-1 - General form for registration of securities under the Securities Act of 1933","titleType":"招股说明书","type":"usProspectusesRegistrations","url":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003107/0001178913-25-003107-index.htm","us_notice_code":"Form S-1","us_title_en":"Form S-1 - General form for registration of securities under the Securities Act of 1933","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"S-1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003107/zk2533703.htm","primary":true,"translateUrl":"","linkName":"zk2533703.htm","type":"S-1","id":"NTFILE5vEQjieuYWG8oDfU","market":"us","size":4092819},{"description":"EXHIBIT 5.1","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003107/exhibit_5-1.htm","primary":false,"translateUrl":"","linkName":"exhibit_5-1.htm","type":"EX-5.1","id":"NTFILE3GTtkk7VUG8gpGHR","market":"us","size":41659},{"description":"EXHIBIT 23.1","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003107/exhibit_23-1.htm","primary":false,"translateUrl":"","linkName":"exhibit_23-1.htm","type":"EX-23.1","id":"NTFILE4LwNGVZugnEadQRv","market":"us","size":5548},{"description":"FILING FEE IXBRL","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003107/ex107.htm","primary":false,"translateUrl":"","linkName":"ex107.htm","type":"EX-FILING FEES","id":"NTFILE4jnm6br6FMVdYemk","market":"us","size":13451},{"description":"GRAPHIC","seq":10,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003107/image00006.jpg","primary":false,"translateUrl":"","linkName":"image00006.jpg","type":"GRAPHIC","id":"NTFILEHK5KvtdzzEwm6koc","market":"us","size":16772},{"description":"GRAPHIC","seq":11,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003107/image1.jpg","primary":false,"translateUrl":"","linkName":"image1.jpg","type":"GRAPHIC","id":"NTFILEE1uuiZ6v7GNnzXy6","market":"us","size":642879},{"description":"GRAPHIC","seq":12,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003107/image3.jpg","primary":false,"translateUrl":"","linkName":"image3.jpg","type":"GRAPHIC","id":"NTFILEGAiLZ8tX3QhvW2fS","market":"us","size":314144},{"description":"GRAPHIC","seq":13,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003107/image4.jpg","primary":false,"translateUrl":"","linkName":"image4.jpg","type":"GRAPHIC","id":"NTFILEFNu2AeeYAjFCMZPd","market":"us","size":335467},{"description":"GRAPHIC","seq":14,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003107/image5.jpg","primary":false,"translateUrl":"","linkName":"image5.jpg","type":"GRAPHIC","id":"NTFILEGr8oFgVC2YJ9WBb2","market":"us","size":784427},{"description":"GRAPHIC","seq":15,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003107/image6.jpg","primary":false,"translateUrl":"","linkName":"image6.jpg","type":"GRAPHIC","id":"NTFILEGWY44eQftaYuHPNB","market":"us","size":1081732},{"description":"GRAPHIC","seq":16,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003107/image7.jpg","primary":false,"translateUrl":"","linkName":"image7.jpg","type":"GRAPHIC","id":"NTFILEHvJ2FKY5yS64Nx35","market":"us","size":377529},{"description":"GRAPHIC","seq":17,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003107/image8.jpg","primary":false,"translateUrl":"","linkName":"image8.jpg","type":"GRAPHIC","id":"NTFILEFYgVDuKM6sdpSJ9F","market":"us","size":233010},{"description":"GRAPHIC","seq":18,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003107/image9.jpg","primary":false,"translateUrl":"","linkName":"image9.jpg","type":"GRAPHIC","id":"NTFILEG9zsqs47Ef8THs6D","market":"us","size":307203},{"description":"GRAPHIC","seq":19,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003107/image10.jpg","primary":false,"translateUrl":"","linkName":"image10.jpg","type":"GRAPHIC","id":"NTFILE9QJ1dEmXFn4HWkT4","market":"us","size":254622},{"description":"GRAPHIC","seq":20,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003107/image11.jpg","primary":false,"translateUrl":"","linkName":"image11.jpg","type":"GRAPHIC","id":"NTFILE4Gi6fbcBorrmmKxe","market":"us","size":484221},{"description":"GRAPHIC","seq":21,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003107/image12.jpg","primary":false,"translateUrl":"","linkName":"image12.jpg","type":"GRAPHIC","id":"NTFILE6VaJHDGZXZjx8LqA","market":"us","size":332930},{"description":"GRAPHIC","seq":22,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003107/image13.jpg","primary":false,"translateUrl":"","linkName":"image13.jpg","type":"GRAPHIC","id":"NTFILEE3Z8C74oyrXsKxPJ","market":"us","size":526125},{"description":"GRAPHIC","seq":23,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003107/image14.jpg","primary":false,"translateUrl":"","linkName":"image14.jpg","type":"GRAPHIC","id":"NTFILE6o93waVuRp11BM6P","market":"us","size":254473},{"description":"GRAPHIC","seq":24,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003107/image15.jpg","primary":false,"translateUrl":"","linkName":"image15.jpg","type":"GRAPHIC","id":"NTFILEAhZStsy7EXaZzy1Z","market":"us","size":305074},{"description":"GRAPHIC","seq":25,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003107/image16.jpg","primary":false,"translateUrl":"","linkName":"image16.jpg","type":"GRAPHIC","id":"NTFILE5sEiWnk96x1ZbkvX","market":"us","size":221415},{"description":"GRAPHIC","seq":26,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003107/image17.jpg","primary":false,"translateUrl":"","linkName":"image17.jpg","type":"GRAPHIC","id":"NTFILEGG9LVRgVxRqTVbJm","market":"us","size":218940},{"description":"GRAPHIC","seq":27,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003107/image00019.jpg","primary":false,"translateUrl":"","linkName":"image00019.jpg","type":"GRAPHIC","id":"NTFILEFYwEZCHz9rQdqCag","market":"us","size":4689},{"description":"GRAPHIC","seq":28,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003107/image00020.jpg","primary":false,"translateUrl":"","linkName":"image00020.jpg","type":"GRAPHIC","id":"NTFILEekH36icHsKrGsyha","market":"us","size":6712},{"description":"GRAPHIC","seq":29,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003107/image00023.jpg","primary":false,"translateUrl":"","linkName":"image00023.jpg","type":"GRAPHIC","id":"NTFILEGVRnJzmftLkBXRvG","market":"us","size":4836}],"type_name":"招股注册","type_name_en":"Recruitment Registration","titleTypeEn":"Public Prospectus","us_type":"usProspectusesRegistrations","us_type_zh":"招股注册","earn_infos":[],"event_type":"important_notice","event_name":"招股说明书","pubTime":"2025-08-26 12:00","pubTimestamp":1756180800,"title_zh":"Form S-1 - General form for registration of securities under the Securities Act of 1933","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20016375","market":"us","labels":[],"media":"sec.gov","original_id":"AN117891325003009-SLXN","pdf_url":"","pub_time":1755662400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form S-8 - Securities to be offered to employees in employee benefit plans","symbol":"SLXN","title":"Form S-8 - Securities to be offered to employees in employee benefit plans","titleType":"员工持股计划","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003009/0001178913-25-003009-index.htm","us_notice_code":"Form S-8","us_title_en":"Form S-8 - Securities to be offered to employees in employee benefit plans","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"S-8","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003009/zk2533683.htm","primary":true,"translateUrl":"","linkName":"zk2533683.htm","type":"S-8","id":"NTFILECMNkqkxM9tfRa3dd","market":"us","size":75197},{"description":"EXHIBIT 5.1","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003009/exhibit_5-1.htm","primary":false,"translateUrl":"","linkName":"exhibit_5-1.htm","type":"EX-5.1","id":"NTFILE5myfeiqP8CjFhF8w","market":"us","size":40897},{"description":"EXHIBIT 23.1","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003009/exhibit_23-1.htm","primary":false,"translateUrl":"","linkName":"exhibit_23-1.htm","type":"EX-23.1","id":"NTFILE3tiW1TEecJwTyo42","market":"us","size":3261},{"description":"","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003009/exfilingfees.htm","primary":false,"translateUrl":"","linkName":"exfilingfees.htm","type":"EX-FILING FEES","id":"NTFILE6Nq1i51GA3vfcGrC","market":"us","size":16067},{"description":"","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003009/image2.jpg","primary":false,"translateUrl":"","linkName":"image2.jpg","type":"GRAPHIC","id":"NTFILEFHKGWoe8bFSv2GFk","market":"us","size":617413},{"description":"","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003009/image00006.jpg","primary":false,"translateUrl":"","linkName":"image00006.jpg","type":"GRAPHIC","id":"NTFILE9x3CUXVbFUMFSEoq","market":"us","size":4813}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Employee Stock Ownership","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"员工持股计划","pubTime":"2025-08-20 12:00","pubTimestamp":1755662400,"title_zh":"Form S-8 - Securities to be offered to employees in employee benefit plans","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20016239","market":"us","labels":[],"media":"sec.gov","original_id":"AN117891325003005-SLXN","pdf_url":"","pub_time":1755662400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"SLXN","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003005/0001178913-25-003005-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"EXHIBIT 99.1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003005/exhibit_99-1.htm","primary":true,"translateUrl":"","linkName":"exhibit_99-1.htm","type":"EX-99.1","id":"NTFILE8v8ko6Enfb48A7a6","market":"us","size":1454617},{"description":"8-K","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003005/zk2533676.htm","primary":false,"translateUrl":"","linkName":"zk2533676.htm","type":"8-K","id":"NTFILE7QzXzvLMBDaVpAM1","market":"us","size":46487},{"description":"GRAPHIC","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325003005/image00006.jpg","primary":false,"translateUrl":"","linkName":"image00006.jpg","type":"GRAPHIC","id":"NTFILEAhK79tRwQBaMZKYj","market":"us","size":16772}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2025-08-20 12:00","pubTimestamp":1755662400,"title_zh":"Form 8-K - Current report","summary_en":"Item 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"项目8.01：其他事件；项目9.01：财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20009280","market":"us","labels":[],"media":"sec.gov","original_id":"AN117891325002985-SLXN","pdf_url":"","pub_time":1755576000000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"SLXN","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325002985/0001178913-25-002985-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year;\nItem 5.07: Submission of Matters to a Vote of Security Holders;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"EXHIBIT 3.1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325002985/exhibit_3-1.htm","primary":true,"translateUrl":"","linkName":"exhibit_3-1.htm","type":"EX-3.1","id":"NTFILEE1USSkXhaMdtE5K3","market":"us","size":6348},{"description":"8-K","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325002985/zk2533680.htm","primary":false,"translateUrl":"","linkName":"zk2533680.htm","type":"8-K","id":"NTFILE3Z4z99vAeXwTQkp7","market":"us","size":54997}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2025-08-19 12:00","pubTimestamp":1755576000,"title_zh":"Form 8-K - Current report","summary_en":"Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year;\nItem 5.07: Submission of Matters to a Vote of Security Holders;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第5.03项：公司章程或章程的修订；财政年度的变化；项目5.07：将事项提交证券持有人表决；项目9.01：财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19977406","market":"us","labels":[],"media":"sec.gov","original_id":"AN117891325002804-SLXN","pdf_url":"","pub_time":1754971200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","symbol":"SLXN","title":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","titleType":"季度报告","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325002804/0001178913-25-002804-index.htm","us_notice_code":"Form 10-Q","us_title_en":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"10-Q","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325002804/zk2533520.htm","primary":true,"translateUrl":"","linkName":"zk2533520.htm","type":"10-Q","id":"NTFILEFKF9bLXCxeqFruiR","market":"us","size":1766268},{"description":"EXHIBIT 31.1","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325002804/exhibit_31-1.htm","primary":false,"translateUrl":"","linkName":"exhibit_31-1.htm","type":"EX-31.1","id":"NTFILEHqPg7LuvCjfrB6xt","market":"us","size":13080},{"description":"EXHIBIT 31.2","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325002804/exhibit_31-2.htm","primary":false,"translateUrl":"","linkName":"exhibit_31-2.htm","type":"EX-31.2","id":"NTFILEF8FWH4fYBEhGZt4Q","market":"us","size":13278},{"description":"EXHIBIT 32.1","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325002804/exhibit_32-1.htm","primary":false,"translateUrl":"","linkName":"exhibit_32-1.htm","type":"EX-32.1","id":"NTFILE5xt91FjCgGDhErxK","market":"us","size":6187},{"description":"EXHIBIT 32.2","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325002804/exhibit_32-2.htm","primary":false,"translateUrl":"","linkName":"exhibit_32-2.htm","type":"EX-32.2","id":"NTFILEhSp4zurhznu73TqW","market":"us","size":6207}],"type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Quarterly Report","us_type":"usFinancials","us_type_zh":"财务报告","earn_infos":[],"event_type":"important_notice","event_name":"季度报告","pubTime":"2025-08-12 12:00","pubTimestamp":1754971200,"title_zh":"Form 10-Q - Quarterly report [Sections 13 or 15(d","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19976131","market":"us","labels":[],"media":"sec.gov","original_id":"AN117891325002784-SLXN","pdf_url":"","pub_time":1754971200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"SLXN","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325002784/0001178913-25-002784-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 2.02: Results of Operations and Financial Condition;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"EXHIBIT 99.1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325002784/exhibit_99-1.htm","primary":true,"translateUrl":"","linkName":"exhibit_99-1.htm","type":"EX-99.1","id":"NTFILEAsb3kbZadQocnNzp","market":"us","size":137284},{"description":"8-K","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325002784/zk2533609.htm","primary":false,"translateUrl":"","linkName":"zk2533609.htm","type":"8-K","id":"NTFILEFXUHV7gMe39KWnZt","market":"us","size":49081},{"description":"","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325002784/image00004.jpg","primary":false,"translateUrl":"","linkName":"image00004.jpg","type":"GRAPHIC","id":"NTFILE5aQcNrmsziXFzD2q","market":"us","size":3406}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2025-08-12 12:00","pubTimestamp":1754971200,"title_zh":"Form 8-K - Current report","summary_en":"Item 2.02: Results of Operations and Financial Condition;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第2.02项：经营业绩和财务状况；项目9.01：财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19938662","market":"us","labels":[],"media":"sec.gov","original_id":"AN117891325002570-SLXN","pdf_url":"","pub_time":1754020800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"SLXN","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325002570/0001178913-25-002570-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 3.02: Unregistered Sales of Equity Securities;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"EXHIBIT 10.1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325002570/exhibit_10-1.htm","primary":true,"translateUrl":"","linkName":"exhibit_10-1.htm","type":"EX-10.1","id":"NTFILE5iFYs4MvUAwBCHfk","market":"us","size":52841},{"description":"8-K","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325002570/zk2533522.htm","primary":false,"translateUrl":"","linkName":"zk2533522.htm","type":"8-K","id":"NTFILE6PL1nKyuCrRgDxuR","market":"us","size":77620},{"description":"EXHIBIT 10.2","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325002570/exhibit_10-2.htm","primary":false,"translateUrl":"","linkName":"exhibit_10-2.htm","type":"EX-10.2","id":"NTFILED3JPu7skP1exTXUU","market":"us","size":117245},{"description":"","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325002570/exhibit_10-3.htm","primary":false,"translateUrl":"","linkName":"exhibit_10-3.htm","type":"EX-10.3","id":"NTFILEGmndmxMReans3WWo","market":"us","size":103816}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2025-08-01 12:00","pubTimestamp":1754020800,"title_zh":"Form 8-K - Current report","summary_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 3.02: Unregistered Sales of Equity Securities;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第1.01项：签订重大最终协议；第3.02项：未经登记的股本证券销售；项目9.01：财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19932454","market":"us","labels":[],"media":"sec.gov","original_id":"AN117891325002559-SLXN","pdf_url":"","pub_time":1753934400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"SLXN","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325002559/0001178913-25-002559-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 7.01: Regulation FD Disclosure;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"EXHIBIT 99.1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325002559/exhibit_99-1.htm","primary":true,"translateUrl":"","linkName":"exhibit_99-1.htm","type":"EX-99.1","id":"NTFILE8tT9kaNsJhPvtw4j","market":"us","size":16935},{"description":"8-K","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325002559/zk2533519.htm","primary":false,"translateUrl":"","linkName":"zk2533519.htm","type":"8-K","id":"NTFILE4uFaqPKKemVemVN5","market":"us","size":49892},{"description":"","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325002559/image0.jpg","primary":false,"translateUrl":"","linkName":"image0.jpg","type":"GRAPHIC","id":"NTFILE5DhG6wn1CrTnHGRD","market":"us","size":35519},{"description":"","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325002559/image00001.jpg","primary":false,"translateUrl":"","linkName":"image00001.jpg","type":"GRAPHIC","id":"NTFILE7GLK2BV7b8MM2D5z","market":"us","size":65360}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2025-07-31 12:00","pubTimestamp":1753934400,"title_zh":"Form 8-K - Current report","summary_en":"Item 7.01: Regulation FD Disclosure;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第7.01项：法规FD披露；项目9.01：财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19921317","market":"us","labels":[],"media":"sec.gov","original_id":"AN117891325002515-SLXN","pdf_url":"","pub_time":1753761600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"SLXN","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325002515/0001178913-25-002515-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 3.03: Material Modifications to Rights of Security Holders;\nItem 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year;\nItem 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"EXHIBIT 3.1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325002515/exhibit_3-1.htm","primary":true,"translateUrl":"","linkName":"exhibit_3-1.htm","type":"EX-3.1","id":"NTFILEEck6UuGqXtoxxmzH","market":"us","size":8346},{"description":"8-K","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325002515/zk2533495.htm","primary":false,"translateUrl":"","linkName":"zk2533495.htm","type":"8-K","id":"NTFILE3t6gCqvwLHE2gtSQ","market":"us","size":60717},{"description":"EXHIBIT 4.1","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325002515/exhibit_4-1.htm","primary":false,"translateUrl":"","linkName":"exhibit_4-1.htm","type":"EX-4.1","id":"NTFILE2CnNJYYhKk96aZqi","market":"us","size":12203}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2025-07-29 12:00","pubTimestamp":1753761600,"title_zh":"Form 8-K - Current report","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19897800","market":"us","labels":[],"media":"sec.gov","original_id":"AN117891325002431-SLXN","pdf_url":"","pub_time":1753070400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"SLXN","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325002431/0001178913-25-002431-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"8-K","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2022416/000117891325002431/zk2533462.htm","primary":true,"translateUrl":"","linkName":"zk2533462.htm","type":"8-K","id":"NTFILEHTScrEQfENQMFyGU","market":"us","size":54676}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2025-07-21 12:00","pubTimestamp":1753070400,"title_zh":"Form 8-K - Current report","summary_en":"Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing","summary_zh":"第3.01项：除牌通知或未能符合持续上市规则或标准；转让上市","notice_type":"","filling_tag":"","gpt_icon":0}],"currentPage":1,"bottom":false},"companyData":{"profile":{"websiteUrl":"http://www.silexion.com","stockEarnings":[{"period":"1week","weight":-0.4308},{"period":"1month","weight":-0.45},{"period":"3month","weight":-0.6898},{"period":"6month","weight":-0.7929},{"period":"1year","weight":-0.9726},{"period":"ytd","weight":-0.865}],"compareEarnings":[{"period":"1week","weight":0.0157},{"period":"1month","weight":0.0194},{"period":"3month","weight":0.1012},{"period":"6month","weight":0.1681},{"period":"1year","weight":0.1759},{"period":"ytd","weight":0.1217}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Silexion Therapeutics Corp是一家开曼群岛豁免公司。Silexion Therapeutics Ltd.是Biomotion Sciences的子公司。Silexion Therapeutics Ltd.是一家临床阶段、专注于肿瘤学的生物技术公司，致力于发现和开发KRAS驱动的癌症的专有疗法。Silexion的主要候选产品SIL-204B由局部给药的小干扰RNA或siRNA组成，采用缓释制剂，作为局部晚期胰腺癌患者的一线治疗，与标准护理化疗相结合。SIL-204B是继Silexion的第一代siRNA候选产品SIG12D-LODER（也称为Loder）的1期和2期临床试验之后的第二代siRNA候选产品。尽管未确定最大耐受剂量，但1期临床试验同时达到了主要和次要终点。在2期临床试验中，虽然没有达到所有患者的主要终点，但结果显示KRAS G12D/V突变患者的治疗组之间存在差异趋势，Loder组的总体生存期优势为9.3个月。关于2期临床试验中的次要安全性终点，达到了终点。对于次要疗效终点，未观察到统计学上的显著差异，也没有足够的数据进行评估。由于1期和2期试验的规模较小，它们没有提供统计学意义。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.0087},{"month":2,"riseRate":0.75,"avgChangeRate":-0.104682},{"month":3,"riseRate":1,"avgChangeRate":0.013692},{"month":4,"riseRate":0.75,"avgChangeRate":-0.019534},{"month":5,"riseRate":0.4,"avgChangeRate":0.010327},{"month":6,"riseRate":0.4,"avgChangeRate":-0.035519},{"month":7,"riseRate":1,"avgChangeRate":0.055675},{"month":8,"riseRate":0.4,"avgChangeRate":-0.277749},{"month":9,"riseRate":0.6,"avgChangeRate":-0.212572},{"month":10,"riseRate":0.5,"avgChangeRate":-0.107747},{"month":11,"riseRate":0.5,"avgChangeRate":0.013201},{"month":12,"riseRate":0.25,"avgChangeRate":-0.069674}],"exchange":"NASDAQ","name":"Silexion Therapeutics Corp","nameEN":"Silexion Therapeutics Corp"},"aProfile":null}}}